Hertzel Gerstein, MD

Hertzel Gerstein, MD
 

Professor of Medicine
McMaster University Faculty of Health Sciences
Hamilton, Ontario, Canada

What is the physiologic rationale of combining GLP-1 RAs and basal insulin into fixed ratio combination agents such as iGlarLixi and iDegLira? Video

What is the physiologic rationale of combining GLP-1 RAs and basal insulin into fixed ratio combination agents such as iGlarLixi and iDegLira?

What is the physiologic rationale of combining GLP-1 RAs and basal insulin into fixed ratio combination agents such as iGlarLixi and iDegLira?
Hertzel Gerstein, MD

Hertzel Gerstein, MD

What is the role of PPG in comprehensive HA1c level control? How early in T2D management do you think fixed ratio, combination basal insulin-GLP-1 RA formulations play a role? Video

What is the role of PPG in comprehensive HA1c level control? How early in T2D management do you think fixed ratio, combination basal insulin-GLP-1 RA formulations play a role?

What is the role of PPG as a determinant of achieving comprehensive HA1c level control? And how early in the course of T2D management do you think fixed ratio, combination basal insulin-GLP-1 RA formulations play a role?
Hertzel Gerstein, MD

Hertzel Gerstein, MD

What are the still unanswered questions about combination basal insulin-GLP-1 RA formulations? Video

What are the still unanswered questions about combination basal insulin-GLP-1 RA formulations?

What are the still unanswered questions about combination basal insulin-GLP-1 RA formulations?
Hertzel Gerstein, MD

Hertzel Gerstein, MD

What is your interpretation of the results from the studies evaluating the effectiveness and safety of fixed ratio insulin-GLP-1 RA combinations? Video

What is your interpretation of the results from the studies evaluating the effectiveness and safety of fixed ratio insulin-GLP-1 RA combinations?

What is your interpretation of the results from the studies evaluating the effectiveness and safety of fixed ratio insulin-GLP-1 RA combinations?
Hertzel Gerstein, MD

Hertzel Gerstein, MD

For what reasons does insulin remain a foundational therapy for managing patients with T2D? And why does the addition of a GLP-1 RA potentially augment the utility of insulin-based management? Video

For what reasons does insulin remain a foundational therapy for managing patients with T2D? And why does the addition of a GLP-1 RA potentially augment the utility of insulin-based management?

For what reasons does insulin remain a foundational therapy for managing patients with T2D? And why does the addition of a GLP-1 RA potentially augment the utility of insulin-based management?
Hertzel Gerstein, MD

Hertzel Gerstein, MD